Loading…
Preventing Overdoses with Test Strips Act
Legislative Progress
Introduced
September 28, 2023
Latest Action
September 29, 2023
Primary Sponsor
Josh GottheimerDemocratic(NJ)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
53pct
1d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2024 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the EQUAL Act, H.R. 1062 and S. 524; supporting the Sentencing Commission Improvements Act, S. 851; supporting the Fresh Start Act, H.R. 2983; supporting the Clean Slate Act, H.R. 2930 / S. 5266; supporting the FAIR Act, H.R. 1525 / S. 5512; supporting the Kenneth P. Thompson Begin Again Act, H.R. 4958 and S. 2596; supporting the TEST Act, S. 1950; supporting the Prohibiting Punishment of Acquitted Conduct Act, S. 2788 and H.R. 5430; supporting the Preventing Overdoses with Test Strips Act, S.2976 and H.R.5801; supporting the BOP ID Release Card Act, H.R. 6985;supporting the BOP Direct-Hire Authority Act, H.R. 6628; supporting the Safer Supervision Act, S.2681 and H.R.5005; supporting the DEA's reclassification of marijuana as a Schedule 3 drug; supporting USSC amendments to drug penalties, relevant conduct sentencing, and numerous sentencing enhancements; opposing proposed appropriations cuts to the federal indigent defense system; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; and supporting clemencies, commutations, and pardons, opposing the HALT Fentanyl Act, H.R. 467; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; supporting Second Chance Act reauthorization; opposing proposed BOP rule to ban the use of social media by incarcerated persons; supporting the Prohibiting Punishment of Acquitted Conduct Ave, S. 2788 and H.R. 5430; opposing the Combating Illicit Xylazine Act, H.R. 1839 and S. 993; supporting the Driving for Opportunity Act, S. 2313; opposing the SHIELD Act, S. 412 and H.R. 3686; opposing proposed appropriations cuts to the federal indigent defense system; supporting the Reentry Act (H.R.2400 / S.1165) and Due Process Continuity of Care Act (H.R.3074 / S.971); and supporting the implementation of tobacco harm reduction policies.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $40,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
2024 · third_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the EQUAL Act, H.R. 1062 and S. 524; supporting the Sentencing Commission Improvements Act, S. 851; supporting the Fresh Start Act, H.R. 2983; supporting the Clean Slate Act, H.R. 2930; supporting the FAIR Act, H.R. 1525; supporting the Kenneth P. Thompson Begin Again Act, H.R. 4958 and S. 2596; supporting the TEST Act, S. 1950; supporting the Federal Prison Oversight Act, H. R. 3019 and S. 1401; supporting the Prohibiting Punishment of Acquitted Conduct Act, S. 2788 and H.R. 5430; supporting the Preventing Overdoses with Test Strips Act, S.2976 and H.R.5801; supporting the BOP ID Release Card Act, H.R. 6985; supporting the Interdiction of Fentanyl in Postal Mail at Federal Prisons Act, H.R. 5266; supporting the BOP Direct-Hire Authority Act, H.R. 6628; supporting the Safer Supervision Act, S.2681 and H.R.5005; supporting the DEA's reclassification of marijuana as a Schedule 3 drug; supporting USSC amendments to drug penalties, relevant conduct sentencing, and numerous sentencing enhancements; opposing proposed appropriations cuts to the federal indigent defense system; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; and supporting clemencies, commutations, and pardons. Opposing the HALT Fentanyl Act, H.R. 467; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; supporting Second Chance Act reauthorization; opposing proposed BOP rule to ban the use of social media by incarcerated persons; supporting the Prohibiting Punishment of Acquitted Conduct Ave, S. 2788 and H.R. 5430; opposing the Combating Illicit Xylazine Act, H.R. 1839 and S. 993; supporting the Driving for Opportunity Act, S. 2313; opposing the SHIELD Act, S. 412 and H.R. 3686; opposing proposed appropriations cuts to the federal indigent defense system; supporting adequate funding for public defenders; and supporting the implementation of tobacco harm reduction policies.
Client expense: $20,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
2024 · second_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the EQUAL Act, H.R. 1062 and S. 524; supporting the Sentencing Commission Improvements Act, S. 851; supporting the Fresh Start Act, H.R. 2983; supporting the Clean Slate Act, H.R. 2930; supporting the FAIR Act, H.R. 1525; supporting the Kenneth P. Thompson Begin Again Act, H.R. 4958 and S. 2596; supporting the TEST Act, S. 1950; supporting the Federal Prison Oversight Act, H. R. 3019 and S. 1401; supporting the Prohibiting Punishment of Acquitted Conduct Act, S. 2788 and H.R. 5430; supporting the Preventing Overdoses with Test Strips Act, S.2976 and H.R.5801; supporting the BOP ID Release Card Act, H.R. 6985; supporting the Interdiction of Fentanyl in Postal Mail at Federal Prisons Act, H.R. 5266; supporting the BOP Direct-Hire Authority Act, H.R. 6628; supporting the Safer Supervision Act, S.2681 and H.R.5005; supporting the DEA's reclassification of marijuana as a Schedule 3 drug; supporting USSC amendments to drug penalties, relevant conduct sentencing, and numerous sentencing enhancements; opposing proposed appropriations cuts to the federal indigent defense system; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; and supporting clemencies, commutations, and pardons. Opposing the HALT Fentanyl Act, H.R. 467; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; supporting Second Chance Act reauthorization; and opposing proposed BOP rule to ban the use of social media by incarcerated persons.
Client expense: $30,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
2024 · first_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the EQUAL Act, H.R. 1062 and S. 524; supporting the Sentencing Commission Improvements Act, S. 851; supporting the Fresh Start Act, H.R. 2983; supporting the Clean Slate Act, H.R. 2930; supporting the FAIR Act, H.R. 1525; supporting the Kenneth P. Thompson Begin Again Act, H.R. 4958 and S. 2596; supporting the TEST Act, S. 1950; supporting the Federal Prison Oversight Act, H. R. 3019 and S. 1401; supporting the Prohibiting Punishment of Acquitted Conduct Act, S. 2788 and H.R. 5430; supporting the Preventing Overdoses with Test Strips Act, S.2976 and H.R.5801; opposing S.J.Res. 47 and H.J.Res.97, which would undo CARES Act home confinement; supporting the BOP ID Release Card Act, H.R. 6985; supporting the Interdiction of Fentanyl in Postal Mail at Federal Prisons Act, H.R. 5266; supporting the BOP Direct-Hire Authority Act, H.R. 6628; opposing proposed appropriations cuts to the federal indigent defense system; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; and supporting clemencies, commutations, and pardons. Opposing the HALT Fentanyl Act, H.R. 467; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; supporting Second Chance Act reauthorization; and opposing proposed BOP rule to ban the use of social media by incarcerated persons.
Client expense: $30,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
2023 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the EQUAL Act, H.R. 1062 and S. 524; supporting the Sentencing Commission Improvements Act, S. 851; supporting the Fresh Start Act, H.R. 2983; supporting the Clean Slate Act, H.R. 2930; supporting the FAIR Act, H.R. 1525; supporting the Kenneth P. Thompson Begin Again Act, H.R. 4958 and S. 2596; supporting the TEST Act, S. 1950; supporting the Federal Prison Oversight Act, H. R. 3019 and S. 1401; supporting the Prohibiting Punishment of Acquitted Conduct Act, S. 2788 and H.R. 5430; supporting the Preventing Overdoses with Test Strips Act, S.2976 and H.R.5801; opposing S.J.Res. 47 and H.J.Res.97, which would undo CARES Act home confinement; supporting Small Business Administrations proposed rule to eliminate existing criminal background requirements for SBA-backed loan and surety programs for small business owners; supporting the BOP ID Release Card Act, H.R. 6985; supporting the Interdiction of Fentanyl in Postal Mail at Federal Prisons Act, H.R. 5266; supporting the BOP Direct-Hire Authority Act, H.R. 6628; opposing proposed appropriations cuts to the federal indigent defense system; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; and supporting clemencies, commutations, and pardons. Opposing the HALT Fentanyl Act, H.R. 467; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general.
Client expense: $40,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
2023 · second_quarter · Health Issues
H.R.3281 Transparent P.R.I.C.E Act H.R.5801 Help Ensure Lower Patient Copays Act S.1339 the Pharmacy Benefit Manager Reform Act IRA implementation, prescription drug access and affordability, pricing, transparency
Client expense: Not reported · Firm income: $60,000
2023 · second_quarter · Health Issues
H.R. 3281 Transparent P.R.I.C.E Act H.R. 5801 Help Ensure Lower Patient Copays Act S. 1339 the Pharmacy Benefit Manager Reform Act 340B, transparency, prescription drug pricing and access, beneficiary access, IRA implementation
Client expense: Not reported · Firm income: $60,000
2023 · second_quarter · Health Issues
H.R.3281 Transparent P.R.I.C.E Act H.R.5801 Help Ensure Lower Patient Copays Act S.1339 the Pharmacy Benefit Manager Reform Act IRA implementation, supply chain integrity, innovation, 340B, transparency
Client expense: Not reported · Firm income: $80,000
2023 · second_quarter · Health Issues
H.R.3281 Transparent P.R.I.C.E Act H.R.5801 Help Ensure Lower Patient Copays Act S.1339 the Pharmacy Benefit Manager Reform Act IRA implementation, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines
Client expense: Not reported · Firm income: $50,000
2023 · second_quarter · Health Issues
S.1339 the Pharmacy Benefit Manager Reform Act H.R.3281 Transparent P.R.I.C.E Act H.R.5801 Help Ensure Lower Patient Copays Act IRA implementation, 340B, orphan drug issues, oncology, price transparency, adherence
Client expense: Not reported · Firm income: $80,000
2022 · third_quarter · Health Issues
H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress Commitment to America-GOP Public Policy plan- monitoring developments H.R.5376 Inflation Reduction Act- Support passage.
2022 · fourth_quarter · Health Issues
S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress
2022 · fourth_quarter · Health Issues
S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress
2022 · third_quarter · Health Issues
H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress Commitment to America-GOP Public Policy plan- monitoring developments H.R.5376 Inflation Reduction Act- Support passage.
2022 · third_quarter · Health Issues
H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress Commitment to America-GOP Public Policy plan- monitoring developments H.R.5376 Inflation Reduction Act- Support passage.
2022 · third_quarter · Health Issues
H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress Commitment to America-GOP Public Policy plan- monitoring developments H.R.5376 Inflation Reduction Act- Support passage.
2022 · second_quarter · Health Issues
H.R. 1319 - American Rescue Plan Act of 2021 - support passage H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $42,877 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $58,169 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $45,264 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $11,123 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $11,123 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $42,877 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $42,877 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE